Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve Replacement (TAVR/TAVI) in Australia
Launched by CARANX MEDICAL · Aug 12, 2025
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new computer program called TAVIPILOT that helps doctors place a heart valve more accurately during a procedure called TAVI, which is used to treat a condition where the heart’s aortic valve is narrowed. The software works like a guide, using real-time imaging and smart technology to show important parts of the heart and help position the new valve just right. The goal is to see if this software is safe to use and if it helps make the valve placement more precise, which could improve the overall success of the procedure.
The trial is open to adults aged 65 and older who need TAVI through the leg artery (called transfemoral TAVI) because of severe narrowing of their aortic valve. If you take part, doctors will use the TAVIPILOT software during your valve replacement to assist with positioning. This study is just starting to recruit participants, and it focuses on making the procedure safer and more accurate by using this new technology alongside the usual imaging methods.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients aged ≥65
- • 2. Indicated for transfemoral TAVR for severe aortic stenosis
About Caranx Medical
Caranx Medical is a clinical trial sponsor specializing in the development and advancement of innovative medical devices and therapeutic solutions. Committed to improving patient outcomes, Caranx Medical focuses on rigorous research and collaboration with healthcare professionals to bring cutting-edge technologies from concept to clinical application. Their expertise spans various medical fields, emphasizing safety, efficacy, and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported